INTRODUCTION
============

Tuberculosis is a global health problem, with approximately 8.8 million new cases and 1.4 million deaths reported in 2010.[@B1] The disease is caused by members of the *Mycobacterium tuberculosis* (*M. tuberculosis*) complex, a group of closely related species and subspecies, which include *M. tuberculosis*, *M. africanum*, *M. bovis*, *M. bovis* bacillus Calmette-Guérin (BCG), *M. microti*, *M. canettii*, *M. pinnipedii*, and *M. mungi*.[@B2] *M. tuberculosis* is the most common cause of tuberculosis in humans. *M. bovis* causes tuberculosis in humans and animals, and is responsible for 10 to 15% of new human tuberculosis cases in developing countries.[@B3] *M. bovis* BCG, a live attenuated strain of *M. bovis*, is a widely used anti-tuberculosis vaccine, and is used for the treatment of bladder cancer.[@B4] However, *M. bovis* BCG is known to lead to complications, such as osteomyelitis, abscesses, lymphadenitis, and dissemination of *M. bovis* BCG, most severely in human immunodeficiency virus-infected neonates and children. In *M. bovis* BCG-treated patients, complications such as pneumonitis, hepatitis and noncaseating granulomas have been reported.[@B5]

Identification of the *M. tuberculosis* complex to the species level is important for public health, epidemiology and treatment.[@B6] In the laboratory, tuberculosis is diagnosed by acid-fast bacilli (Ziehl-Neelsen) staining and culturing of mycobacteria, followed by identification of the cultured mycobacteria. For more rapid identification, several polymerase chain reaction (PCR)-based methods have been developed, and PCR assay that targets *M. tuberculosis*-specific sequences, including IS*6110* and the MPT64 gene, has been widely applied.[@B7] However, while this assay can differentiate the *M. tuberculosis* complex from nontuberculous mycobacteria, it cannot identify the *M. tuberculosis* complex to the species level.[@B7] For rapid and efficient identification of the *M. tuberculosis* complex, several PCR-based methods have been developed.[@B8]-[@B10] However, these are rarely used as a routine test in diagnostic laboratories as they require two rounds of PCR reaction and electrophoresis to distinguish the *M. tuberculosis* complex from other mycobacteria and to identify *M. tuberculosis* complex to the species level.[@B11],[@B12] Moreover, identification of nontuberculous mycobacteria to the species level is of greater importance due to the increased incidence of infection with nontuberculous mycobacteria. Thus, more rapid and efficient methods of identification are needed.

A well-validated probe for the *Mycobacterium* genus targets the conserved sequence of the *rpo*B gene, which encodes the β subunit of RNA polymerase, and not only facilitates identification of all *Mycobacterium* spp., but also distinguishes *Mycobacterium* spp. at the species level by restriction enzyme analysis.[@B13] In a comparative genomics study of *M. tuberculosis* H37Rv, 16 regions of the genome (regions of difference, RD) were shown to be deleted in *M. bovis* and *M. bovis* BCG.[@B10] One of them, RD1, is present in virulent *M. tuberculosis* complex strains, including *M. tuberculosis* and *M. bovis*, but is absent in *M. bovis* BCG, allowing for *M. tuberculosis* and *M. bovis* to be differentiated from *M. bovis* BCG.[@B11],[@B12] Additionally, a novel RD8 is present in *M. tuberculosis* and *M. africanum* that is deleted in *M. bovis* and *M. bovis* BCG and absent in *M. microti* and nontuberculous mycobacteria.[@B14]

In this study, we developed a rapid and efficient multiplex PCR assay that enables not only the identification of the genus *Mycobacterium* using the *rpo*B sequence conserved in all mycobacteria, but also the identification of the *M. tuberculosis* complex to the species level, using RD1 and RD8 sequences. The assay was shown to be simple and efficient in identifying *Mycobacterium* genus and distinguishing the *M. tuberculosis* complex to the species level.

MATERIALS AND METHODS
=====================

Bacterial strains
-----------------

The bacterial strains used in this study are listed in [Table 1](#T1){ref-type="table"}. Seventy-six clinical *M. tuberculosis* isolates from humans and 52 clinical *M. bovis* isolates from cattle were provided kindly from Yonsei University College of Medicine, Seoul, Korea. Twenty-seven clinical *M. avium* isolates and 23 clinical *M. intracellulare* isolates from humans were provided by the Korea Institute of Tuberculosis, Osong, Korea.

Culture media and DNA extraction
--------------------------------

Bacterial culture and chromosomal DNA isolation were performed as previously described.[@B13] Briefly, bacteria were cultured on Middlebrook 7H9 media (Difco, Detroit, MI, USA) supplemented with 10% Middlebrook OADC Enrichment media (BBL, Sparks, MD, USA) at 37℃ for 2 to 4 weeks. Bacterial cells were collected by centrifugation at 10000×g, resuspended in distilled water, and boiled for 10 min. Cell debris was sedimented by centrifugation for 2 min at 10000×g, and the resultant DNA concentration was measured using a spectrophotometer (260 nm, Amersham Pharmacia Biotech Inc., Piscataway, NJ, USA). DNA was stored at -20℃ prior to use.

PCR primer design
-----------------

The primers used in this study are listed in [Table 2](#T2){ref-type="table"}. The genome sequence of *M. tuberculosis* H37Rv was imported into the Vector NTI® Software (Life technologies, Grand Island, NY, USA), and *rpo*B, RD1 and RD8 were created according to the genome address. Primers were selected by analysis of the appropriate genomic regions using Primer 3 software (<http://frodo.wi.mit.edu/>) ([Fig. 1](#F1){ref-type="fig"}, [Table 2](#T2){ref-type="table"}).

PCR amplification
-----------------

The amplification reaction mixture consisted of 10 mM Tri-HCl, 50 mM KCl, 1.5 mM MgCl~2~, 200 µM of each primer, 1.5 units of *Taq* DNA polymerase (Bioneer, Daejeon, Korea), and 20 ng of genomic DNA as the template. PCR amplification was performed in an automated thermal cycler (PTC-100 Programmable Thermal Controller, MJ Research, Inc., Waltham, MA, USA). The cycling parameters were 94℃ for 5 min, followed by 35 cycles of denaturation at 94℃ for 30 s, annealing at 68℃ for 30 s and a final extension at 72℃ for 7 min. Sterile distilled water was used as a negative control. Analysis of PCR products was performed by electrophoresis in ethidium bromide (0.5 µg/mL)-stained 1.7 % (w/v) agarose gels.

RESULTS
=======

Validation of the PCR method
----------------------------

PCR conditions were optimized with four sets of primer pairs using *M. tuberculosis* H37Rv, *M. bovis* AN5 and *M. bovis* BCG Pasteur as representative strains ([Figs. 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}), and confirmed using all bacterial strains by gel electrophoresis. The PCR products for each target sequence from each set of primer pairs were also confirmed. All reference mycobacterial strains consistently yielded a single 518-bp product with primers rpoB-F and rpoB-R, but other bacterial strains yielded no products, indicating that all mycobacterial strains contained the specific *rpo*B gene ([Table 3](#T3){ref-type="table"}). *M. tuberculosis* H37Rv, *M. africanum* and *M. bovis* AN5 consistently yielded a single 254-bp product with RD1-F and RD1-R primers, but other bacterial strains, including all *M. bovis* BCG strains and *M. microti*, yielded no product with RD1-F and RD1-R primers, indicating the RD1 sequence is present in virulent *M. tuberculosis* complex strains. *M. tuberculosis* and *M. africanum* type strains consistently yielded a single 150-bp product with RD8-F and RD8-T-R primers, but yielded no product with RD8-F and RD8-T-R primers, indicating the presence of the RD8 sequence. Conversely, *M. bovis* and all *M. bovis* BCG strains consistently yielded a single 360-bp product with RD8-F and RD8-B-R primers, but yielded no product with RD8-F and RD8-T-R primers, indicating a deletion of the RD8 sequence in *M. bovis*, including *M. bovis* BCG ([Fig. 1](#F1){ref-type="fig"}, [Table 3](#T3){ref-type="table"}). However, other bacteria, including nontuberculous mycobacteria and *M. microti*, yielded no product with either RD8-F and RD8-T-R or RD8-F and RD8-B-R primers.

Multiplex PCR on reference strains and clinical isolates
--------------------------------------------------------

PCR products using the four sets of primer pairs were performed on 30 reference strains and 178 clinical isolates ([Figs. 3](#F3){ref-type="fig"}, [4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"}). Multiplex PCR of *M. tuberculosis* H37Rv and *M. tuberculosis* Erdman yielded three 518-, 254- and 150-bp products, indicating the presence of *rpo*B, RD1 and RD8, respectively ([Fig. 4](#F4){ref-type="fig"}). Multiplex PCR of 76 clinical *M. tuberculosis* isolates provided results identical to the *M. tuberculosis* reference strain ([Fig. 4](#F4){ref-type="fig"}). Multiplex PCR of *M. africanum*, a member of the *M. tuberculosis* complex, yielded results identical to *M. tuberculosis* ([Fig. 3](#F3){ref-type="fig"}). However, multiplex PCR of *M. microti* yielded only a 518-bp product, similar to nontuberculous mycobacteria.

Multiplex PCR on *M. bovis* AN5 and 52 clinical *M. bovis* isolates yielded 518-, 360- and 254-bp products, indicating the presence of *rpo*B and RD1, as well as the deletion of RD8 ([Fig. 5](#F5){ref-type="fig"}). All four *M. bovis* BCG strains yielded 518- and 360-bp products, indicating the presence of *rpo*B, the absence of RD1 and the deletion of RD8. Multiplex PCR of 23 nontuberculous mycobacteria reference strains and 50 clinical nontuberculous mycobacteria isolates yielded only a 518-bp product, indicating the absence of RD1 and RD8. Multiplex PCR of other non-mycobacterial bacteria yielded no positive results. The data were consistently reproducible, and complete concordance between independent researchers was confirmed.

DISCUSSION
==========

We developed a simple and effective multiplex PCR assay that enabled the differentiation of *Mycobacteria* spp. from other bacteria and identified the *M. tuberculosis* complex to the species level. Our analysis using reference strains and clinical isolates suggested that the multiplex PCR assay is specific for *M. tuberculosis*, *M. bovis* and *M. bovis* BCG, as well as nontuberculosis mycobacteria. The conserved *rpo*B sequence of the mycobacteria was used to differentiate the genus *Mycobacterium* from other bacteria, resulting in data specific for all *Mycobacteria* spp. tested.[@B13] Moreover, the fragment length polymorphism of the 518-bp PCR products targeting *rpo*B were effective for species identification (data not shown). This sequence offers advantages over other target sequences, including IS*6110* and 16S RNA. IS*6110* can be used for the detection of *M. tuberculosis* complex, but cannot differentiate members of the *M. tuberculosis* complex.[@B7] 16S RNA has been used for the identification of *Mycobacteria* spp., but is unable to provide identification of *M. tuberculosis* complex to the species level, due to their high similarity.[@B15] The present assay was based on the detection of RD1 and RD8 in order to distinguish members of the *M. tuberculosis* complex. Using this assay, RD1 was detected in all *M. tuberculosis* complex strains, including *M. tuberculosis*, *M. bovis* and *M. africanum*, but not *M. bovis* BCG or *M. microti*, in accordance with previous reports.[@B11],[@B12] RD8 was detected in *M. tuberculosis* and *M. africanum*, but a deleted form of RD8 was detected in *M. bovis* and *M. bovis* BCG. Interestingly, this sequence was absent in *M. microti* even though *M. microti* belongs to the *M. tuberculosis* complex. This result was in agreement with previous reports that demonstrated the presence of RD8 in *M. tuberculosis*, but not *M. microti*.[@B16] In our study, the *M. africanum* reference strain (ATCC 25420) contained RD8; however, investigation using other *M. africanum* strains would be necessary since Vasconcellos, et al.[@B17] reported RD8 to be present in the West African-1 lineage, but absent from the West African-2 lineage. Our assay using RD8 possessed advantages over other RDs, including RD4 and RD9, since RD8 can distinguish mycobacteria to three groups, *M. tuberculosis* and *M. africanum*, *M. bovis* and *M. bovis* BCG, and *M. microti* and nontuberculous mycobacteria, by determining the presence of RD8, the deletion of RD8 or the absence of RD8, respectively. Conversely, RD4 and RD9 can distinguish between *M. tuberculosis* and *M. bovis*, including *M. bovis* BCG, but not between *M. africanum* and *M. microtii*.[@B11] Multiplex PCR assays that target RD8 combined with RD1 effectively distinguish the *M. tuberculosis* complex to the species level.

Several methods of identifying the *M. tuberculosis* complex currently exist, including high-performance liquid chromatography,[@B18] restriction fragment length polymorphism,[@B7],[@B8] and spoligotyping.[@B19] However, these assays are generally not used routinely in clinical microbiology laboratories as they are time consuming and costly. Recently, multiplex PCR assays have been proposed as a diagnostic method due to a single reaction and multiple targets.[@B7],[@B11],[@B12] The present assay is the first multiplex PCR assay shown to identify the *Mycobacterium* genus and distinguish the *M. tuberculosis* complex to the species level by targeting the *rpo*B sequence, as well as RD1 and RD8 sequences, respectively.

This assay can be used as a routine diagnostic test in microbiology laboratories and may contribute to determination of an optimal treatment regimen, improve the surveillance of tuberculous disease due to members of the *M. tuberculosis* complex, and aid in the identification of the *M. tuberculosis* complex and nontuberculous mycobacteria.
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![Schematic diagram showing regions flanking the direct repeat region in *M. tuberculosis* H37Rv, *M. bovis* and *M. bovis* bacillus Calmette-Guérin (BCG). This region is specifically deleted in *M. bovis* and *M. bovis* BCG, indicated by dotted lines. Primer positions are indicated by small arrows. RD, regions of difference.](ymj-54-1220-g001){#F1}

![Multiplex PCR for *M. tuberculosis*, *M. bovis* and *M. bovis* bacillus Calmette-Guérin (BCG) strains. PCR products were separated by electrophoresis and visualized. Lanes M: molecular size marker (100-bp ladder); 1: *M. bovis* BCG Pasteur; 2: *M. bovis* BCG Tice; 3: *M. bovis* BCG Tokyo; 4: *M. bovis* AN5; 5: *M. tuberculosis* H37Rv; 6: negative control. Expected sizes of PCR products are shown. RD, regions of difference; PCR, polymerase chain reaction; ESAT-6, early secreted antigenic target 6 kDa protein.](ymj-54-1220-g002){#F2}

![Multiplex PCR for the *Mycobacterium* species. PCR products were separated by electrophoresis and visualized. Lanes M: molecular size marker (100-bp ladder); 1: *M. avium*; 2: *M. africanum*; 3: *M. abscesses*; 4: *M. celatum*; 5: *M. chelonae*; 6: *M. fortuitum*; 7: *M. gordonae*; 8: *M. intracellulare*; 9: *M. kansasii*; 10: *M. marinum*; 11: *M. microtii*; 12: *M. phlei*; 13: *M. septicum*; 14: *M. szulgai*; 15: *M. terrae*; 16: *M. ulcerans*; PCR, polymerase chain reaction.](ymj-54-1220-g003){#F3}

![Multiplex PCR for clinical *M. tuberculosis* isolates. PCR products were separated by electrophoresis and visualized. Lanes M: molecular size marker (100-bp ladder); 1-15: *M. tuberculosis* isolates; 16: *M. tuberculosis* H37Rv; 17: *M. tuberculosis* Erdman; PCR, polymerase chain reaction.](ymj-54-1220-g004){#F4}

![Multiplex PCR for clinical *M. bovis* isolates. PCR products were separated by electrophoresis and visualized. Lanes M: molecular size marker (100-bp ladder); 1-20: *M. bovis* isolates; 21: *M. bovis* AN5; 22: *M. bovis* BCG Pasteur; 23: *M. tuberculosis* H37Rv. BCG, bacillus Calmette-Guérin; PCR, polymerase chain reaction.](ymj-54-1220-g005){#F5}

###### 

Bacterial Strains Used in This Study
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YUMC, Yonsei University College of Medicine, Seoul, Korea; KIT, Korea Institute of Tuberculosis, Osong, Korea; BCG, bacillus Calmette-Guérin.

###### 

Primers Used in This Study
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RD, regions of difference.

###### 

Signature Patterns of Positive and Negative Multiplex PCR Used to Discriminate Mycobacterial Strains
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RD, regions of difference; BCG, bacillus Calmette-Guérin; PCR, polymerase chain reaction; NTM, non-tuberculous Mycobacteria.
